Telix Pharma shares gain on Citi backing of ITM deal
Telix Pharmaceuticals shares rise as much as 6.8% to A$16.83, their biggest intraday percentage gain since September 15. The stock had fallen 11.7% on Monday after the company agreed to buy Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis. Citigroup believes ITM's